Innate Immunity Stimulation Via TLR9 in Early AD

Abroad (travel likely)RecruitingPHASE1

Conditions

Mild Cognitive Impairment · Alzheimer Dementia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

NYU Langone Health, New York, New York, United States

Study leads

Arjun Masurkar, MD
Principal Investigator
NYU Langone Medical Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Multifocal tDCS-EEG Protocol for Improving Symptoms of Mild Cognitive Impairment and Early Dementia

Mild Cognitive Impairment (MCI) · Dementia · Alzheimer Disease, Early Onset

Abroad (travel likely)Recruiting

Caserta, Italy

Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol

Alzheimer Disease · Mild Cognitive Impairment · Dementia

Abroad (travel likely)RecruitingPHASE2

Englewood, United States

Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease

Dementia · Alzheimers Disease · Mild Cognitive Impairment Due to Alzheimer's Disease

Abroad (travel likely)RecruitingPHASE2

Boston, United States

Study to Understand Novel Biomarkers in Researching Dementia

Alzheimer Disease · Mild Cognitive Impairment · Dementia

Abroad (travel likely)Recruiting

St Louis, United States